Advertisement

Topics

‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost

05:00 EDT 23 Aug 2017 | Kaiser Health News

A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.

Original Article: ‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost

NEXT ARTICLE

More From BioPortfolio on "‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...